VRDN

Viridian Therapeutics Inc

$19.26

0.00 (0.00%) Today

1.16 (6.41%) Pre-market

— up— down

Market Cap

$1.76B+31.4%

Revenue (TTM)

$76.62M+23382.8%

Net Income (TTM)

$-437,059,854

$-437,059,854

EPS (TTM)

-3.96

-3.96

Shares Out

110.43M

110.43M

Open

$18.37

$18.37

Previous Close

$18.37

$18.37

Day Range

$18.18 – $19.19

$18.18 – $19.19

52-Week Range

$13.18 – $34.29

$13.18 – $34.29

Beta

0.91

0.91

Volume

3.33M

3.33M

Avg Volume

2.58M

2.58M

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About VRDN

Related

News

Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease - Slideshow

SeekingAlpha · 6h ago

RBC Capital Maintains Outperform on Viridian Therapeutics, Raises Price Target to $35

Benzinga · 1d ago

Truist Securities Maintains Buy on Viridian Therapeutics, Raises Price Target to $38

Benzinga · 1d ago

Wedbush Maintains Outperform on Viridian Therapeutics, Raises Price Target to $43

Benzinga · 1d ago

Needham Maintains Buy on Viridian Therapeutics, Raises Price Target to $34

Benzinga · 1d ago